國家衛生研究院 NHRI:Item 3990099045/8767
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 955511      線上人數 : 736
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8767


    題名: Pharmacological induction of human fetal globin gene in hydroxyurea-resistant primary adult erythroid cells
    作者: Chou, YC;Chen, RL;Lai, ZS;Song, JS;Chao, YS;Shen, CK
    貢獻者: Institute of Biotechnology and Pharmaceutical Research
    摘要: Pharmacological induction of the fetal gamma globin gene and the consequent formation of HbF (alpha2/gamma2) in adult erythroid cells is one feasible therapeutic strategy for sickle cell disease (SCD) and severe beta-thalassemias. Hydroxyurea (HU) is the current drug of choice for SCD, but the serious side effects limit its clinical use. Moreover, 30-50% of patients are irresponsive to HU treatment. We have used high-throughput screening to identify benzo[de]benzo[4,5]imidazo[2,1-a]isoquinolin-7-one and its derivatives (compounds I-VI) as potent gamma globin-inducers. Of the compounds, I-V exert superior gamma globin-induction and better therapeutic potential than HU, likely because of their activation of the p38 MAPK signaling pathway, modulation of the expression levels and/or chromosome-binding of gamma globin gene regulators including BCL11A, as well as chromatin structure over the gamma globin promoter. Unlike sodium butyrate (NaB), the global levels of acetylated histones H3 and H4 are not changed by compound II treatment. Remarkably, compound II induces the gamma globin gene in HU-resistant primary human adult erythroid cells, the p38 signaling pathway of which appears to be irresponsive to HU, NaB, as well as compound II. This study provides a new framework for the development of new and superior compounds for treating SCD and the severe beta-thalassemias.
    日期: 2015-07
    關聯: Molecular and Cellular Biology. 2015 Jul;35(14):2541-2553.
    Link to: http://dx.doi.org/10.1128/mcb.00035-15
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0270-7306&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000357457900014
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84932621889
    顯示於類別:[趙宇生(2002-2013)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB25986606.pdf2610KbAdobe PDF553檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋